Drug repurposing and the prior art patents of competitors
- 1 December 2014
- journal article
- Published by Elsevier in Drug Discovery Today
- Vol. 19 (12) , 1841-1847
Abstract
No abstract availableKeywords
This publication has 12 references indexed in Scilit:
- An exploratory analysis of patent fencing in pharmaceuticals: The case of PDE5 inhibitorsResearch Policy, 2013
- Secondary Patenting Of Branded Pharmaceuticals: A Case Study Of How Patents On Two HIV Drugs Could Be Extended For DecadesHealth Affairs, 2012
- Repositioned drugs: integrating intellectual property and regulatory strategiesDrug Discovery Today: Therapeutic Strategies, 2011
- Repurposing Strategies for TherapeuticsPharmaceutical Medicine, 2010
- The value of drug repositioning in the current pharmaceutical marketDrug News & Perspectives, 2009
- Product-related research: how research can contribute to successful life-cycle managementDrug Discovery Today, 2008
- Use of Patents in Drug Lifecycle ManagementJournal of Generic Medicines, 2007
- Drug repositioning: identifying and developing new uses for existing drugsNature Reviews Drug Discovery, 2004
- The price of innovation: new estimates of drug development costsJournal of Health Economics, 2003
- Patents and Innovation: An Empirical StudyManagement Science, 1986